应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CPIX 坎伯兰药业
耶稣受难日休市 04-02 16:00:00 EDT
3.17
+0.07
+2.26%
盘后
3.17
+0.00
0.00%
16:10 EDT
最高
3.23
最低
3.00
成交量
8.10万
今开
3.09
昨收
3.10
日振幅
7.26%
总市值
4,741万
流通市值
2,526万
总股本
1,496万
成交额
25.00万
换手率
1.02%
流通股本
796.97万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
坎伯兰药业Ifetroban治疗杜氏肌营养不良症项目获FDA快速通道资格认定
美股速递 · 02-04
坎伯兰药业Ifetroban治疗杜氏肌营养不良症项目获FDA快速通道资格认定
坎伯兰药业盘中异动 股价大涨5.14%报3.89美元
市场透视 · 01-30
坎伯兰药业盘中异动 股价大涨5.14%报3.89美元
坎伯兰药业盘中异动 早盘快速下挫5.25%报4.15美元
市场透视 · 01-22
坎伯兰药业盘中异动 早盘快速下挫5.25%报4.15美元
坎伯兰药业盘中异动 股价大跌5.10%报3.91美元
市场透视 · 2025-12-30
坎伯兰药业盘中异动 股价大跌5.10%报3.91美元
坎伯兰药业盘中异动 早盘急速下挫6.21%
市场透视 · 2025-12-23
坎伯兰药业盘中异动 早盘急速下挫6.21%
坎伯兰药业盘中异动 大幅拉升5.14%报4.09美元
市场透视 · 2025-12-18
坎伯兰药业盘中异动 大幅拉升5.14%报4.09美元
坎伯兰药业盘中异动 下午盘股价大涨5.69%
市场透视 · 2025-11-27
坎伯兰药业盘中异动 下午盘股价大涨5.69%
坎伯兰药业盘中异动 快速拉升6.52%报2.13美元
市场透视 · 2025-11-13
坎伯兰药业盘中异动 快速拉升6.52%报2.13美元
坎伯兰药业盘中异动 下午盘股价大跌7.16%报3.24美元
市场透视 · 2025-10-28
坎伯兰药业盘中异动 下午盘股价大跌7.16%报3.24美元
坎伯兰药业宣布将一家已获得FDA批准的成熟产品纳入其商业组合
美股速递 · 2025-10-20
坎伯兰药业宣布将一家已获得FDA批准的成熟产品纳入其商业组合
坎伯兰药业的Vibativ®纳入与Premier, Inc.的全国集团采购协议
美股速递 · 2025-10-13
坎伯兰药业的Vibativ®纳入与Premier, Inc.的全国集团采购协议
坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元
市场透视 · 2025-03-10
坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元
坎伯兰药业盘中异动 快速下跌5.32%
市场透视 · 2025-03-06
坎伯兰药业盘中异动 快速下跌5.32%
坎伯兰药业盘中异动 大幅跳水6.78%
市场透视 · 2025-03-05
坎伯兰药业盘中异动 大幅跳水6.78%
Cumberland(CPIX.US):2024年Q4财报实现营收1043.6万美元,前值为935.3万美元;每股收益为-0.02美元,前值为-0.11美元。
金融界 · 2025-03-05
Cumberland(CPIX.US):2024年Q4财报实现营收1043.6万美元,前值为935.3万美元;每股收益为-0.02美元,前值为-0.11美元。
坎伯兰公司第四季度每股调整亏损从去年同期的$(0.11)缩小至$(0.02),销售额从$9.35M增长至$10.44M
财报速递 · 2025-03-05
坎伯兰公司第四季度每股调整亏损从去年同期的$(0.11)缩小至$(0.02),销售额从$9.35M增长至$10.44M
坎伯兰药业盘中异动 早盘股价大跌5.14%报4.88美元
市场透视 · 2025-03-04
坎伯兰药业盘中异动 早盘股价大跌5.14%报4.88美元
坎伯兰药业盘中异动 股价大涨5.12%报5.11美元
市场透视 · 2025-03-03
坎伯兰药业盘中异动 股价大涨5.12%报5.11美元
坎伯兰药业盘中异动 下午盘急速下跌5.23%报4.71美元
市场透视 · 2025-03-01
坎伯兰药业盘中异动 下午盘急速下跌5.23%报4.71美元
坎伯兰药业盘中异动 股价大跌5.20%
市场透视 · 2025-02-28
坎伯兰药业盘中异动 股价大跌5.20%
加载更多
公司概况
公司名称:
坎伯兰药业
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cumberland Pharmaceuticals Inc.于1999年注册成立。专注于品牌处方产品的收购、开发和商业化,是一家不断发展的专业制药公司。该公司的主要目标市场是医院的急症护理和胃肠病,其特征是该公司认为可以有效地通过相对小,针对性的销售力量渗透相对集中的医师开具处方基地。该公司致力于提供能够为患者提高护理质量和解决很难达到的医疗要求的创新产品。公司拥有产品开发和商业能力,并相信可以利用其现有的基础设施,以支持其预期的增长。公司的管理团队由医药行业资深人士组成。其在业务发展,产品开发,商业和金融方面经历丰富。该公司的业务开发团队识别,评估及谈判产品收购,进口许可和出口许可的机会。该公司的产品开发团队开发专有产品配方,管理其临床试验,准备所有的监管意见书及管理其医疗呼叫中心。该公司的高品质的和专业制造人士监督其产品的生产。该公司的市场营销和销售的专业人士负责其商业活动,而该公司与第三方分销合作伙伴密切合作,以确保可用性和交付其产品。
发行价格:
--
{"stockData":{"symbol":"CPIX","market":"US","secType":"STK","nameCN":"坎伯兰药业","latestPrice":3.17,"timestamp":1775160000000,"preClose":3.1,"halted":0,"volume":80983,"hourTrading":{"tag":"盘后","latestPrice":3.17,"preClose":3.17,"latestTime":"16:10 EDT","volume":102,"amount":323.34,"timestamp":1775160604406,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02258064516129027,"floatShares":7969656,"shares":14956627,"eps":-0.19,"marketStatus":"耶稣受难日休市","change":0.07,"latestTime":"04-02 16:00:00 EDT","open":3.09,"high":3.225,"low":3,"amount":250018.327086,"amplitude":0.072581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.19,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1249963200000,"exchange":"NASDAQ","adjPreClose":3.1,"postHourTrading":{"tag":"盘后","latestPrice":3.17,"preClose":3.17,"latestTime":"16:10 EDT","volume":102,"amount":323.34,"timestamp":1775160604406,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.734200471343966,"impliedVol":0.5522,"impliedVolPercentile":0.2351},"requestUrl":"/m/hq/s/CPIX","defaultTab":"news","newsList":[{"id":"1107332408","title":"坎伯兰药业Ifetroban治疗杜氏肌营养不良症项目获FDA快速通道资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1107332408","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107332408?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:06","pubTimestamp":1770213971,"startTime":"0","endTime":"0","summary":"坎伯兰药业宣布,其研发的Ifetroban用于治疗杜氏肌营养不良症(Duchenne Muscular Dystrophy, DMD)的项目,已获得美国食品药品监督管理局(FDA)授予的快速通道资格(Fast Track Designation)。这一认定将加速该药物的开发与审评进程,为患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4557","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607071520","title":"坎伯兰药业盘中异动 股价大涨5.14%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607071520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607071520?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:54","pubTimestamp":1769784884,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日22时54分,坎伯兰药业股票出现异动,股价急速拉升5.14%。截至发稿,该股报3.89美元/股,成交量1.4176万股,换手率0.09%,振幅8.38%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.32%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013022544497a43508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013022544497a43508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605428728","title":"坎伯兰药业盘中异动 早盘快速下挫5.25%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605428728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605428728?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:37","pubTimestamp":1769092639,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日22时37分,坎伯兰药业股票出现波动,股价大幅下挫5.25%。截至发稿,该股报4.15美元/股,成交量2.6738万股,换手率0.18%,振幅4.58%。坎伯兰药业股票所在的制药行业中,整体涨幅为0.02%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122223720a44a5df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122223720a44a5df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595763802","title":"坎伯兰药业盘中异动 股价大跌5.10%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595763802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595763802?lang=zh_cn&edition=full","pubTime":"2025-12-30 00:41","pubTimestamp":1767026509,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日00时41分,坎伯兰药业股票出现波动,股价大幅下挫5.10%。截至发稿,该股报3.91美元/股,成交量7.1093万股,换手率0.48%,振幅5.17%。坎伯兰药业股票所在的制药行业中,整体涨幅为0.53%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230004150a486ce2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230004150a486ce2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593642716","title":"坎伯兰药业盘中异动 早盘急速下挫6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593642716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593642716?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:53","pubTimestamp":1766501605,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时53分,坎伯兰药业股票出现波动,股价大幅下挫6.21%。截至发稿,该股报4.08美元/股,成交量8653股,换手率0.06%,振幅5.75%。坎伯兰药业股票所在的制药行业中,整体涨幅为0.92%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225325a6c66f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225325a6c66f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592676631","title":"坎伯兰药业盘中异动 大幅拉升5.14%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592676631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592676631?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:32","pubTimestamp":1766068365,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时32分,坎伯兰药业股票出现异动,股价急速拉升5.14%。截至发稿,该股报4.09美元/股,成交量8634股,换手率0.06%,振幅3.60%。坎伯兰药业股票所在的制药行业中,整体涨幅为0.62%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218223246953b6c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218223246953b6c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586228925","title":"坎伯兰药业盘中异动 下午盘股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586228925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586228925?lang=zh_cn&edition=full","pubTime":"2025-11-27 04:06","pubTimestamp":1764187615,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日04时06分,坎伯兰药业股票出现异动,股价急速上涨5.69%。截至发稿,该股报2.23美元/股,成交量3.4686万股,换手率0.23%,振幅4.27%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.18%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127040655a4bc6e1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127040655a4bc6e1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583045653","title":"坎伯兰药业盘中异动 快速拉升6.52%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583045653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583045653?lang=zh_cn&edition=full","pubTime":"2025-11-13 01:43","pubTimestamp":1762969410,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日01时43分,坎伯兰药业股票出现波动,股价大幅拉升6.52%。截至发稿,该股报2.13美元/股,成交量4.2546万股,换手率0.28%,振幅8.50%。坎伯兰药业股票所在的制药行业中,整体涨幅为1.47%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113014330a49cf40a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113014330a49cf40a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578396604","title":"坎伯兰药业盘中异动 下午盘股价大跌7.16%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578396604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578396604?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:34","pubTimestamp":1761590099,"startTime":"0","endTime":"0","summary":"北京时间2025年10月28日02时34分,坎伯兰药业股票出现异动,股价急速下挫7.16%。截至发稿,该股报3.24美元/股,成交量2.186万股,换手率0.15%,振幅5.73%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.41%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取收购、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028023459a6d1359f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028023459a6d1359f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","CPIX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110573268","title":"坎伯兰药业宣布将一家已获得FDA批准的成熟产品纳入其商业组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1110573268","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110573268?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:06","pubTimestamp":1760965577,"startTime":"0","endTime":"0","summary":"坎伯兰药业宣布将一家已获得FDA批准的成熟产品纳入其商业组合","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116029109","title":"坎伯兰药业的Vibativ®纳入与Premier, Inc.的全国集团采购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1116029109","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116029109?lang=zh_cn&edition=full","pubTime":"2025-10-13 21:06","pubTimestamp":1760360779,"startTime":"0","endTime":"0","summary":"坎伯兰药业的Vibativ®纳入与Premier, Inc.的全国集团采购协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518240662","title":"坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518240662?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:37","pubTimestamp":1741613843,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时37分,坎伯兰药业股票出现波动,股价急速下挫5.34%。截至发稿,该股报6.03美元/股,成交量1.1541万股,换手率0.08%,振幅3.69%。坎伯兰药业股票所在的制药行业中,整体跌幅为0.72%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372398a29e3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372398a29e3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161845","title":"坎伯兰药业盘中异动 快速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161845?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:40","pubTimestamp":1741272033,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时40分,坎伯兰药业股票出现异动,股价急速跳水5.32%。截至发稿,该股报6.41美元/股,成交量6979股,换手率0.05%,振幅4.82%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.69%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224033989eb689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224033989eb689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517945608","title":"坎伯兰药业盘中异动 大幅跳水6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517945608?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分,坎伯兰药业股票出现异动,股价急速跳水6.78%。截至发稿,该股报5.64美元/股,成交量3.4431万股,换手率0.25%,振幅0.00%。坎伯兰药业股票所在的制药行业中,整体涨幅为0.00%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223056abe9b05e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517981705","title":"Cumberland(CPIX.US):2024年Q4财报实现营收1043.6万美元,前值为935.3万美元;每股收益为-0.02美元,前值为-0.11美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981705","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517981705?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:29","pubTimestamp":1741123795,"startTime":"0","endTime":"0","summary":"Cumberland(CPIX.US):2024年Q4财报实现营收1043.6万美元,前值为935.3万美元;每股收益为-0.02美元,前值为-0.11美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05052948524501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157702377","title":"坎伯兰公司第四季度每股调整亏损从去年同期的$(0.11)缩小至$(0.02),销售额从$9.35M增长至$10.44M","url":"https://stock-news.laohu8.com/highlight/detail?id=1157702377","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157702377?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:14","pubTimestamp":1741122891,"startTime":"0","endTime":"0","summary":"坎伯兰报告季度每股亏损为$,与去年同期的每股亏损$相比增长了81.82%。以上内容来自Benzinga Earnings专栏,原文如下:Cumberland reported quarterly losses of $ per share. This is a 81.82 percent increase over losses of $ per share from the same period last year. The company reported $10.44 million in sales this quarter. This is a 11.58 percent increase over sales of $9.35 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"坎伯兰公司第四季度每股调整亏损从去年同期的$(0.11)缩小至$(0.02),销售额从$9.35M增长至$10.44M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670496","title":"坎伯兰药业盘中异动 早盘股价大跌5.14%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670496?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:48","pubTimestamp":1741099702,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时48分,坎伯兰药业股票出现波动,股价急速跳水5.14%。截至发稿,该股报4.88美元/股,成交量7952股,换手率0.06%,振幅3.79%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.33%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224822a25f0a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224822a25f0a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634923","title":"坎伯兰药业盘中异动 股价大涨5.12%报5.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634923?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:42","pubTimestamp":1741012956,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时42分,坎伯兰药业股票出现波动,股价急速上涨5.12%。截至发稿,该股报5.11美元/股,成交量1.0086万股,换手率0.07%,振幅4.52%。最近的财报数据显示,该股实现营业收入9.09百万美元,净利润-1.54百万美元,每股收益-0.11美元,毛利6.65百万美元,市盈率-6.70倍。坎伯兰药业股票所在的制药行业中,整体涨幅为0.30%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224236a25d4301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224236a25d4301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516303110","title":"坎伯兰药业盘中异动 下午盘急速下跌5.23%报4.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516303110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516303110?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:20","pubTimestamp":1740770419,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时20分,坎伯兰药业股票出现波动,股价大幅下跌5.23%。截至发稿,该股报4.71美元/股,成交量3.1804万股,换手率0.23%,振幅6.64%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体涨幅为0.32%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010320199896b7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010320199896b7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332046","title":"坎伯兰药业盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332046?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:34","pubTimestamp":1740688446,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时34分,坎伯兰药业股票出现波动,股价大幅下挫5.20%。截至发稿,该股报4.92美元/股,成交量2.5017万股,换手率0.18%,振幅6.94%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。坎伯兰药业股票所在的制药行业中,整体跌幅为0.32%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043406a256caac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043406a256caac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","CPIX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cumberlandpharma.com","stockEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.3079},{"period":"3month","weight":-0.2035},{"period":"6month","weight":0.0128},{"period":"1year","weight":-0.2593},{"period":"ytd","weight":-0.2035}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cumberland Pharmaceuticals Inc.于1999年注册成立。专注于品牌处方产品的收购、开发和商业化,是一家不断发展的专业制药公司。该公司的主要目标市场是医院的急症护理和胃肠病,其特征是该公司认为可以有效地通过相对小,针对性的销售力量渗透相对集中的医师开具处方基地。该公司致力于提供能够为患者提高护理质量和解决很难达到的医疗要求的创新产品。公司拥有产品开发和商业能力,并相信可以利用其现有的基础设施,以支持其预期的增长。公司的管理团队由医药行业资深人士组成。其在业务发展,产品开发,商业和金融方面经历丰富。该公司的业务开发团队识别,评估及谈判产品收购,进口许可和出口许可的机会。该公司的产品开发团队开发专有产品配方,管理其临床试验,准备所有的监管意见书及管理其医疗呼叫中心。该公司的高品质的和专业制造人士监督其产品的生产。该公司的市场营销和销售的专业人士负责其商业活动,而该公司与第三方分销合作伙伴密切合作,以确保可用性和交付其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":-0.010073},{"month":2,"riseRate":0.411765,"avgChangeRate":0.072503},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.047181},{"month":4,"riseRate":0.235294,"avgChangeRate":-0.035557},{"month":5,"riseRate":0.5,"avgChangeRate":-0.028693},{"month":6,"riseRate":0.5,"avgChangeRate":-0.013146},{"month":7,"riseRate":0.5,"avgChangeRate":0.010736},{"month":8,"riseRate":0.4375,"avgChangeRate":-0.033019},{"month":9,"riseRate":0.470588,"avgChangeRate":0.009283},{"month":10,"riseRate":0.470588,"avgChangeRate":-0.026342},{"month":11,"riseRate":0.588235,"avgChangeRate":0.054604},{"month":12,"riseRate":0.411765,"avgChangeRate":0.075652}],"exchange":"NASDAQ","name":"坎伯兰药业","nameEN":"Cumberland Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"坎伯兰药业(CPIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供坎伯兰药业(CPIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"坎伯兰药业,CPIX,坎伯兰药业股票,坎伯兰药业股票老虎,坎伯兰药业股票老虎国际,坎伯兰药业行情,坎伯兰药业股票行情,坎伯兰药业股价,坎伯兰药业股市,坎伯兰药业股票价格,坎伯兰药业股票交易,坎伯兰药业股票购买,坎伯兰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"坎伯兰药业(CPIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供坎伯兰药业(CPIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}